Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1994 Jun;112(2):635–639. doi: 10.1111/j.1476-5381.1994.tb13122.x

Effects of isocarbacyclin, a stable prostacyclin analogue, on monkey isolated cerebral and peripheral arteries.

Y Kawai 1, T Ohhashi 1
PMCID: PMC1910352  PMID: 8075881

Abstract

1. The effects of isocarbacyclin (TEI 7165), a stable prostacyclin analogue, were examined in monkey isolated cerebral and peripheral arteries. 2. Addition of TEI 7165 (0.1 nM-10 microM) produced a dose-dependent relaxation in cerebral arteries pre-contracted with 1 microM 5-hydroxytryptamine (5-HT). High concentrations (more than 1 microM) of TEI 7165 elicited a transient contraction followed by a sustained relaxation. 3. TEI 7165 also elicited a dose-dependent relaxation in the peripheral (except popliteal) arteries. The maximum relaxation induced by 10 microM TEI 7165 was greater (P < 0.05) in the mesenteric artery than in the cerebral artery. The negative logarithm of the EC50 value for the mesenteric, 7.6 +/- 0.3, was greater (P < 0.05) than that for the cerebral artery, 6.4 +/- 0.3. The decreasing order of potency for the TEI 7165-induced relaxation was as follows: mesenteric > renal > cerebral > coronary > popliteal. 4. Removal of the endothelium did not significantly affect TEI 7165-induced relaxations. 5. The transient contraction produced by high concentrations of TEI 7165 was not observed in cerebral arteries precontracted with 1 nM U46619, a stable analogue of thromboxane A2 (TXA2). Furthermore, the TEI 7165-induced contraction was markedly suppressed (P < 0.05) by treatment with 10 nM S1452, a TXA2 blocking agent. 6. These results suggest that TEI 7165 causes an endothelium-independent relaxation in monkey cerebral and peripheral arteries, and that there is a marked regional difference in the TEI 7165-induced relaxations. A high concentration of TEI 7165 also produces a transient contraction which is probably through activation of TXA2 (TP-) receptors.

Full text

PDF
635

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brandt L., Ljunggren B., Andersson K. E., Hindfelt B., Uski T. Effects of indomethacin and prostacyclin on isolated human pial arteries contracted by CSF from patients with aneurysmal SAH. J Neurosurg. 1981 Dec;55(6):877–883. doi: 10.3171/jns.1981.55.6.0877. [DOI] [PubMed] [Google Scholar]
  2. Chapleau C. E., White R. P. Effects of prostacyclin on the canine isolated basilar artery. Prostaglandins. 1979 Apr;17(4):573–580. doi: 10.1016/0090-6980(79)90008-x. [DOI] [PubMed] [Google Scholar]
  3. Dong Y. J., Jones R. L., Wilson N. H. Prostaglandin E receptor subtypes in smooth muscle: agonist activities of stable prostacyclin analogues. Br J Pharmacol. 1986 Jan;87(1):97–107. doi: 10.1111/j.1476-5381.1986.tb10161.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dusting G. J., Moncada S., Vane J. R. Prostacyclin (PGI2) is a weak contractor of coronary arteries of the pig. Eur J Pharmacol. 1977 Oct 1;45(3):301–304. doi: 10.1016/0014-2999(77)90014-0. [DOI] [PubMed] [Google Scholar]
  5. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov 27;288(5789):373–376. doi: 10.1038/288373a0. [DOI] [PubMed] [Google Scholar]
  6. Hadházy P., Malomvölgyi B., Magyar K. Differential contractile responsiveness of isolated rabbit arteries from different vascular beds to cyclooxygenase inhibitors and PGI2. Eur J Pharmacol. 1984 Mar 2;98(3-4):323–330. doi: 10.1016/0014-2999(84)90280-2. [DOI] [PubMed] [Google Scholar]
  7. Hanasaki K., Arita H. Characterization of a new compound, S-145, as a specific TXA2 receptor antagonist in platelets. Thromb Res. 1988 May 1;50(3):365–376. doi: 10.1016/0049-3848(88)90266-6. [DOI] [PubMed] [Google Scholar]
  8. Hayashi S., Park M. K., Kuehl T. J. Relaxant and contractile responses to prostaglandins in premature, newborn and adult baboon cerebral arteries. J Pharmacol Exp Ther. 1985 Jun;233(3):628–635. [PubMed] [Google Scholar]
  9. Hoshi K., Mizushima Y. A preliminary double-blind cross-over trial of lipo-PGI2, a prostacyclin derivative incorporated in lipid microspheres, in cerebral infarction. Prostaglandins. 1990 Aug;40(2):155–164. doi: 10.1016/0090-6980(90)90081-6. [DOI] [PubMed] [Google Scholar]
  10. Kawai Y., Ohhashi T. Heterogeneity in responses of isolated monkey arteries and veins to atrial natriuretic peptide. Can J Physiol Pharmacol. 1989 Apr;67(4):326–330. doi: 10.1139/y89-053. [DOI] [PubMed] [Google Scholar]
  11. Kawai Y., Ohhashi T. Prostaglandin F2 alpha-induced endothelium-dependent relaxation in isolated monkey cerebral arteries. Am J Physiol. 1991 May;260(5 Pt 2):H1538–H1543. doi: 10.1152/ajpheart.1991.260.5.H1538. [DOI] [PubMed] [Google Scholar]
  12. Kennedy I., Coleman R. A., Humphrey P. P., Levy G. P., Lumley P. Studies on the characterisation of prostanoid receptors: a proposed classification. Prostaglandins. 1982 Nov;24(5):667–689. doi: 10.1016/0090-6980(82)90036-3. [DOI] [PubMed] [Google Scholar]
  13. Levy J. V. Contractile responses to prostacyclin (PGI2) of isolated human saphenous and rat venous tissue. Prostaglandins. 1978 Jul;16(1):93–97. doi: 10.1016/0090-6980(78)90205-8. [DOI] [PubMed] [Google Scholar]
  14. Mizuno-Yagyu Y., Hashida R., Mineo C., Ikegami S., Ohkuma S., Takano T. Effect of PGI2 on transcellular transport of fluorescein dextran through an arterial endothelial monolayer. Biochem Pharmacol. 1987 Nov 15;36(22):3809–3813. doi: 10.1016/0006-2952(87)90442-4. [DOI] [PubMed] [Google Scholar]
  15. Mizushima Y., Igarashi R., Hoshi K., Sim A. K., Cleland M. E., Hayashi H., Goto J. Marked enhancement in antithrombotic activity of isocarbacyclin following its incorporation into lipid microspheres. Prostaglandins. 1987 Feb;33(2):161–168. doi: 10.1016/0090-6980(87)90003-7. [DOI] [PubMed] [Google Scholar]
  16. Moncada S., Vane J. R. Unstable metabolites of arachidonic acid and their role in haemostasis and thrombosis. Br Med Bull. 1978 May;34(2):129–135. doi: 10.1093/oxfordjournals.bmb.a071482. [DOI] [PubMed] [Google Scholar]
  17. Ohtsu A., Fujii K., Kurozumi S. Induction of angiogenic response by chemically stable prostacyclin analogs. Prostaglandins Leukot Essent Fatty Acids. 1988 Jul;33(1):35–39. doi: 10.1016/0952-3278(88)90120-2. [DOI] [PubMed] [Google Scholar]
  18. Oliva D., Noè A., Nicosia S., Bernini F., Fumagalli R., Whittle B. J., Moncada S., Vane J. R. Prostacyclin-sensitive adenylate cyclase in cultured myocytes: differences between rabbit aorta and mesenteric artery. Eur J Pharmacol. 1984 Oct 15;105(3-4):207–213. doi: 10.1016/0014-2999(84)90611-3. [DOI] [PubMed] [Google Scholar]
  19. POOLE J. C., SANDERS A. G., FLOREY H. W. The regeneration of aortic endothelium. J Pathol Bacteriol. 1958 Jan;75(1):133–143. doi: 10.1002/path.1700750116. [DOI] [PubMed] [Google Scholar]
  20. Pickard J., Tamura A., Stewart M., McGeorge A., Fitch W. Prostacyclin, indomethacin and the cerebral circulation. Brain Res. 1980 Sep 22;197(2):425–431. doi: 10.1016/0006-8993(80)91127-0. [DOI] [PubMed] [Google Scholar]
  21. Toda N. Responses to prostaglandins H2 and I2 of isolated dog cerebral and peripheral arteries. Am J Physiol. 1980 Feb;238(2):H111–H117. doi: 10.1152/ajpheart.1980.238.2.H111. [DOI] [PubMed] [Google Scholar]
  22. Uski T. K., Andersson K. E. Effects of prostanoids on isolated feline cerebral arteries. I. Characterization of the contraction-mediating receptor. Acta Physiol Scand. 1984 Jan;120(1):131–136. doi: 10.1111/j.1748-1716.1984.tb07382.x. [DOI] [PubMed] [Google Scholar]
  23. Uski T., Andersson K. E., Brandt L., Edvinsson L., Ljunggren B. Responses of isolated feline and human cerebral arteries to prostacyclin and some of its metabolites. J Cereb Blood Flow Metab. 1983 Jun;3(2):238–245. doi: 10.1038/jcbfm.1983.32. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES